EP0853486A3 - Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases - Google Patents

Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases

Info

Publication number: EP0853486A3
Authority: EP; European Patent Office
Prior art keywords: viral; aids; cancer; treatment; therapeutic applications
Prior art date: 1995-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

EP96932773.3A

Other languages

German (de)

French (fr)

Other versions

EP0853486A4 (en

EP0853486A2 (en

Inventor

Samir Chachoua

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-25

Filing date

1996-09-25

Publication date

1997-06-12

1996-09-25 Application filed by Individual filed Critical Individual

1996-09-25 Priority claimed from PCT/IB1996/001115 external-priority patent/WO1997011667A2/en

1997-06-12 Publication of EP0853486A3 publication Critical patent/EP0853486A3/en

1998-07-22 Publication of EP0853486A2 publication Critical patent/EP0853486A2/en

2001-09-26 Publication of EP0853486A4 publication Critical patent/EP0853486A4/en

Status Withdrawn legal-status Critical Current

Links

EP96932773A 1995-09-25 1996-09-25 Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases Withdrawn EP0853486A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US428195P	1995-09-25	1995-09-25
US4281P		1995-09-25
PCT/IB1996/001115 WO1997011667A2 (en)	1995-09-25	1996-09-25	Therapeutic applications using horse serum

Publications (3)

Publication Number	Publication Date
EP0853486A3 true EP0853486A3 (en)	1997-06-12
EP0853486A2 EP0853486A2 (en)	1998-07-22
EP0853486A4 EP0853486A4 (en)	2001-09-26

Family

ID=21710013

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EP96932773A Withdrawn EP0853486A4 (en)	1995-09-25	1996-09-25	Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases
EP96931214A Withdrawn EP0858327A2 (en)	1995-09-25	1996-09-25	Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
EP96931214A Withdrawn EP0858327A2 (en)	1995-09-25	1996-09-25	Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases

Country Status (5)

Country	Link
EP (2)	EP0853486A4 (en)
JP (1)	JPH11514990A (en)
AU (2)	AU6999096A (en)
CA (2)	CA2233445A1 (en)
WO (2)	WO1997011667A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5994409A (en) *	1997-12-09	1999-11-30	U.S. Bioscience, Inc.	Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6384259B1 (en)	1998-11-16	2002-05-07	Medimmune Oncology, Inc.	Stable amorphous amifostine compositions and dosage form
DE60033830T2 (en) *	1999-10-04	2007-11-15	John Harrow Carter	PHARMACEUTICAL COMPOSITION CONTAINING COPPER, SALICYLIC ACID AND VITAMIN C
US6811788B2 (en)	2000-01-19	2004-11-02	Baofa Yu	Combinations and methods for treating neoplasms
US7927612B2 (en)	2000-01-19	2011-04-19	Baofa Yu	Combinations and methods for treating neoplasms
US6506413B1 (en) *	2001-04-30	2003-01-14	Joseph C. Ramaekers	Compositions for treating animal diseases and syndromes
US7053072B2 (en)	2001-05-11	2006-05-30	Medimmune Oncology, Inc.	Methods for the administration of amifostine and related compounds
FR2825923B1 (en) *	2001-06-15	2006-04-07	Oreal	NO-SYNTHASE INHIBITOR AND USES
KR20030077743A (en) *	2002-03-26	2003-10-04	변현규	The serum of pregancy mare
US7629333B2 (en)	2002-03-29	2009-12-08	Medimmune, Llc	Stable amorphous amifostine compositions and methods for the preparation and use of same
WO2004024129A1 (en) *	2002-09-10	2004-03-25	Samir Chachoua	Induced remission therapy
GB2398497A (en) *	2003-02-19	2004-08-25	Walcom Animal Science	Composition for improving immunity of animals
US9125874B2 (en)	2007-11-30	2015-09-08	The Ramaekers Family Trust	Administration of transfer factor for improving reproductive health
CN101138634A (en)	2006-09-07	2008-03-12	于保法	Composition for treating tumour
EP2278984A4 (en)	2007-11-30	2013-02-27	Ramaekers Family Trust	Compositions and methods for enhancing fertility
US20110311557A1 (en) *	2009-02-11	2011-12-22	Martin Heath Bluth	Reciprocal serum/plasma exchange for the treatment of cancer
CN107106531A (en)	2014-11-26	2017-08-29	于保法	The enhanced chemoimmunotherapy of chemical induction immunotherapy method haptens in minimally invasive accurate individuation knubble

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4228127A (en) *	1978-10-06	1980-10-14	International Radioimmune Systems, Inc.	Kit for detecting human chorionic gonadotropin
US4952607A (en) *	1982-05-27	1990-08-28	International Copper Research Association, Inc.	Copper complex for treating cancer
US5057314A (en) *	1988-09-30	1991-10-15	Whitfill Craig E	Low molecular weight antiviral factors
US5310653A (en) *	1989-10-24	1994-05-10	Board Of Regents, The University Of Texas System	Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis
US5488042A (en) *	1992-03-13	1996-01-30	Arch Development Corporation	Method for protection against genotoxic mutagenesis
DE4236069A1 (en) *	1992-10-26	1994-04-28	Werner Dr Bergmann	Homeopathic medicaments for treating HIV infections - prepd. by dilution of infected serum
WO1994028934A1 (en) *	1993-06-07	1994-12-22	Center For Special Immunology	Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies

1996
- 1996-09-25 JP JP9513260A patent/JPH11514990A/en not_active Ceased
- 1996-09-25 CA CA002233445A patent/CA2233445A1/en not_active Abandoned
- 1996-09-25 AU AU69990/96A patent/AU6999096A/en not_active Abandoned
- 1996-09-25 EP EP96932773A patent/EP0853486A4/en not_active Withdrawn
- 1996-09-25 WO PCT/IB1996/001115 patent/WO1997011667A2/en not_active Application Discontinuation
- 1996-09-25 AU AU71431/96A patent/AU7143196A/en not_active Abandoned
- 1996-09-25 EP EP96931214A patent/EP0858327A2/en not_active Withdrawn
- 1996-09-25 CA CA002233015A patent/CA2233015A1/en not_active Abandoned
- 1996-09-25 WO PCT/IB1996/001059 patent/WO1997011666A2/en not_active Application Discontinuation

Similar Documents

Publication	Publication Date	Title
EP0853486A3 (en)	1997-06-12	Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases
EP0853486A4 (en)	2001-09-26	Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases
AU3066992A (en)	1993-06-07	Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
EP0831873A4 (en)	2002-07-17	The treatment of hiv and other viral infections using combinatory therapy
PL319021A1 (en)	1997-07-21	Body weight modulators, appropriate nucleic acid and proteins and their diagnostic and therapeutic application
EP2270046A3 (en)	2011-03-23	Methods and compositions for the treatment of hemolysis-associated diseases
AU5772196A (en)	1996-11-29	3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772296A (en)	1996-11-29	3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU2990695A (en)	1996-02-22	Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU9312198A (en)	1999-04-05	Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
AU5772396A (en)	1996-11-29	3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5135296A (en)	1996-09-18	Use of protealytic enzymes in the treatment of insect bites
AU6282896A (en)	1997-01-15	Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins
AU3092995A (en)	1997-02-05	Breast specific genes and proteins
AU5847194A (en)	1994-07-04	Novel entomopoxvirus genes, proteins and methods of use thereof
AUPQ344799A0 (en)	1999-11-11	Treatment of respiratory diseases and infections
AU9269898A (en)	1999-04-12	Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
AUPN631395A0 (en)	1995-11-23	Vaccine and biological vector(II)
AU2796799A (en)	1999-09-20	Amplification of gene transfer and gene therapy by controlled replication
HK1015268A (en)	1999-10-15	Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases
AU7529796A (en)	1997-06-05	S-nitroso-hemoglobin and therapeutic uses thereof
AU3530395A (en)	1996-04-19	Treatment of viral infections
GEP20012489B (en)	2001-07-25	Use of Natural Human α-Interferon
AU7478098A (en)	1998-12-08	Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
AU5545896A (en)	1996-11-07	H. Influenzae HxuB and HxuC genes, proteins and methods of use